Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 82

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 82
---
 above. We maintain a website at www.aethlonmedical.com. You may access our annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of
the Exchange Act with the SEC free of charge at our website as soon as reasonably practicable after such material is electronically filed
with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not incorporated by reference
in, and is not part of, this prospectus.

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The
SEC allows us to “incorporate by reference” information from other documents that we file with it, which means that we can
disclose important information to you by referring you to those documents. The information incorporated by reference is considered to
be part of this prospectus. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC
prior to the date of this prospectus.

We
incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents
listed below (except in each case the information contained in such document to the extent “furnished” and not “filed”)
that we have filed with the SEC:

| · 
 · | our Annual Report on Form 10-K for the fiscal                                                                                             
 year ended March 31, 2025 filed with the SEC on June 26, 2026;                                                                            
 our definitive proxy statement on Schedule 14A                                                                                            
 filed with the SEC on April 18, 2025;                                                                                                     |
|:--|:------------------------------------------------------------------------------------------------------------------------------------------|
| · | our Current Report on Form 8-K filed with the                                                                                             
 SEC on June 27, 2025; and                                                                                                                 |
| · | the description of our common stock, which is                                                                                             
 registered under Section 12 of the Exchange Act, in our registration statement on Form 8-A, filed with the SEC on July 8, 2015, including 
 any amendment or reports filed for the purpose of updating such description.                                                              |

| 44 |

In
addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination